Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Seminars in Oncology|April 30, 2003
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerationsSteven P Treon, Abigail Kelliher, Beverly Keele, et al.
Vaccine|March 8, 2017
Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodiesJanie Parrino, Shelly A McNeil, Steven J Lawrence, et al.
Blood|July 20, 2002
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)Jeanette Lundin, Eva Kimby, Magnus Björkholm, et al.
Hemasphere|February 27, 2023
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in SwedenCaroline E Weibull, Tove Wästerlid, Björn Engelbrekt Wahlin, et al.
Medical Oncology (Northwood, London, England)|November 12, 2013
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapseMaciej Machaczka, Jan-Erik Johansson, Mats Remberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
T-cell levels are prognostic in mantle cell lymphomaLina Nygren, Agata M Wasik, Stefanie Baumgartner-Wennerholm, et al.
Leukemia & Lymphoma|May 14, 2013
Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapyBjörn Engelbrekt Wahlin, Christer Sundström, Birgitta Sander, et al.
Annals of Hematology|December 1, 2016
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine aloneBruce D Cheson, Peter C Trask, John G Gribben, et al.
Oncoscience|January 17, 2015
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological featuresAgata M Wasik, Lina Nygren, Stefan Almestrand, et al.
Haematologica|July 2, 2013
Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working PartySilvia Montoto, Paolo Corradini, Martin Dreyling, et al.
Pageof 12